NCT07596784 2026-05-19Efficacy and Safety of Ravulizumab in Chinese Adults Participants With Generalized Myasthenia Gravis (gMG)Alexion Pharmaceuticals, Inc.Phase 3 Not yet recruiting20 enrolled